BetterLife Pharma Inc. (BETR:CC) | Stock Information | Vox Markets
Vox Markets

BetterLife Pharma Inc.

BETR:CC

Recent News

CompanyTitleDate
BETRBetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha1 day ago
BETRBetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special MeetingSep 29, 2026
BETRBetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded WarrantsSep 17, 2026
BETRBetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded WarrantsSep 11, 2026
BETRBetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit CommitteeAug 31, 2026
BETRBetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded WarrantsAug 28, 2026
BETRBetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded WarrantsAug 24, 2026
BETRBetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical OfficerAug 19, 2026
BETRBetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA- Precedented Serotonergic MechanismJul 13, 2026
BETRBetterLife Pharma Announces Appointment of John W. LaRocca to Board of Directors and Audit CommitteeJul 9, 2026
BETRBetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1Jul 6, 2026
BETRBetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1Jun 25, 2026
BETRBetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND FilingJun 22, 2026
BETRBetterLife Pharma Announces Extension of WarrantsJun 19, 2026
BETRBetterLife Pharma Announces Intent to Complete CAD $2 Million in Convertible Debenture to Complete BETR-001 IND FilingJun 15, 2026
BETRBETR Monthly Progress Report - May 2026Jun 2, 2026
BETRBETR Annual Information FormJun 2, 2026
BETRBETR Form 5A - Annual Summary - January 2026May 29, 2026
BETRBETR Annual Audited Consolidated Financial Statements - January 2026May 29, 2026
BETRBETR Annual Management's Discussion and Analysis - January 2026May 29, 2026
Showing 1 to 20 of 35 results

Overview

Classification

Sector Healthcare

Industry Biotechnology & Life Sciences

Subindustry Biotechnology

Financials